1.
Arch Ophthalmol
; 130(1): 120-2, 2012 Jan.
Article
in English
| MEDLINE
| ID: mdl-22232485
Subject(s)
Bupropion/adverse effects , Dopamine Uptake Inhibitors/adverse effects , Glaucoma, Angle-Closure/chemically induced , Uveal Diseases/chemically induced , Adult , Depressive Disorder/drug therapy , Female , Glaucoma, Angle-Closure/diagnostic imaging , Glaucoma, Angle-Closure/drug therapy , Humans , Intraocular Pressure/drug effects , Microscopy, Acoustic , Uveal Diseases/diagnostic imaging , Uveal Diseases/drug therapy , Vision Disorders/chemically induced , Vision Disorders/diagnosis , Visual Acuity
2.
Semin Ophthalmol
; 24(2): 122-5, 2009.
Article
in English
| MEDLINE
| ID: mdl-19373697
ABSTRACT
The use of bevacizumab for the treatment of proliferative diabetic retinopathy, neovascular glaucoma, neovascular age related macular degeneration, and cystoid macular edema has been extensively reported upon. From the published case reports available, bevacizumab may be a useful adjunct to the trabeculectomy procedure.
